Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function

•

Apical surface heparan sulfate proteoglycans (HSPG) have unique endothelial roles.

•

Inflammation and shear stress derangement can alter HSPG synthesis and sulfation.

•

Reduced HSPG expression impacts mechanisms that regulate endothelial cell homeostasis.

•

Changes to endothelial glycocalyx HSPG sulfation are vast and contextually dependent.

•

Targeting endothelial HSPG biosynthesis and sulfation are promising therapeutic strategies.

The glycocalyx attached to the apical surface of vascular endothelial cells is a rich network of proteoglycans, glycosaminoglycans, and glycoproteins with instrumental roles in vascular homeostasis. Given their molecular complexity and ability to interact with the intra- and extracellular environment, heparan sulfate proteoglycans uniquely contribute to the glycocalyx’s role in regulating endothelial permeability, mechanosignaling, and ligand recognition by cognate cell surface receptors. Much attention has recently been devoted to the enzymatic shedding of heparan sulfate proteoglycans from the endothelial glycocalyx and its impact on vascular function. However, other molecular modifications to heparan sulfate proteoglycans are possible and may have equal or complementary clinical significance. In this narrative review, we focus on putative mechanisms driving non-proteolytic changes in heparan sulfate proteoglycan expression and alterations in the sulfation of heparan sulfate side chains within the endothelial glycocalyx. We then discuss how these specific changes to the endothelial glycocalyx impact endothelial cell function and highlight therapeutic strategies to target or potentially reverse these pathologic changes.